Proqr Therapeutics (PRQR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Operating Expenses | 48,397 | 64,338 | 42,862 | 45,775 | 43,792 |
| Operating Income | -48,397 | -64,338 | -42,862 | -45,775 | -43,792 |
| Other Income | -4,709 | 931 | -935 | -3,589 | 520 |
| Pre-tax Income | -53,106 | -63,408 | -43,797 | -49,364 | -43,271 |
| Income Tax | 142 | 148 | 1 | 2 | N/A |
| Net Income Continuous | -53,247 | -63,556 | -43,799 | -49,366 | -43,271 |
| Minority Interests | -56 | N/A | -227 | -43 | N/A |
| Net Income | $-53,191 | $-63,556 | $-43,572 | $-49,323 | $-43,271 |
| EPS Basic Total Ops | -1.06 | -1.55 | -1.28 | -1.94 | -1.86 |
| EPS Basic Continuous Ops | -1.06 | -1.55 | -1.29 | -1.95 | -1.85 |
| EPS Diluted Total Ops | -1.06 | -1.55 | -1.28 | -1.94 | -1.86 |
| EPS Diluted Continuous Ops | -1.06 | -1.55 | -1.29 | -1.95 | -1.85 |
| EPS Diluted Before Non-Recurring Items | -1.06 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-45,707 | $-62,040 | $-41,691 | $-44,571 | $-42,414 |